Wenming Hong
- Immunology top 10%
- Immune cells in cancer 8
- Cancer Research top 10%
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 4
- Rheumatology top 5%
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms 3
- Oncology top 10%
-
- Glioma Diagnosis and Treatment 7
-
- Extracellular vesicles in disease 6
- Single-cell and spatial transcriptomics 3
-
- Meningioma and schwannoma management 3
- Journals
- Oncogene (1 paper)Journal of Allergy and Clinical Immunology (1 paper)Frontiers in Immunology (6 papers)
- Partner nations
- ChinaSaint Kitts and NevisUnited States
In The Last Decade
Wenming Hong
32 papers receiving 969 citations
Peers
Comparison fields: 5 of 85
- Immunology 340
- Cancer Research 205
- Rheumatology 188
- Neurology 83
- Oncology 237
Countries citing papers authored by Wenming Hong
This map shows the geographic impact of Wenming Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenming Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenming Hong more than expected).
Fields of papers citing papers by Wenming Hong
This network shows the impact of papers produced by Wenming Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenming Hong. The network helps show where Wenming Hong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenming Hong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 9 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 59 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 22 | |
| 7 | 2023 | 8 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 13 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 12 | |
| 12 | 2020 | 14 | |
| 13 | 2019 | 44 | |
| 14 | 2019 | 74 | |
| 15 | 2019 | 23 | |
| 16 | 2018 | 95 | |
| 17 | 2017 | 8 | |
| 18 | 2016 | 6 | |
| 19 | 2015 | 10 | |
| 20 | 2014 | 3 |
About Wenming Hong
Wenming Hong is a scholar working on Genetics, Immunology and Cancer Research, having authored 33 papers that have together received 973 indexed citations. Recurring topics across this work include Immune cells in cancer (8 papers), Glioma Diagnosis and Treatment (7 papers), Extracellular vesicles in disease (6 papers), MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers), Single-cell and spatial transcriptomics (3 papers), Meningioma and schwannoma management (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). The work is most often cited by research in Immunology (340 citations), Cancer Research (205 citations) and Rheumatology (188 citations). Wenming Hong has collaborated with scholars based in China, Saint Kitts and Nevis and United States. Frequent co-authors include Wei Wei, Jiajie Tu, Yilong Fang, Xinming Wang, Dafei Han, Pengying Zhang, Ya-Wei Guo, Heinrich Körner, Xuewen Tan and Yizhao Chen. Their work appears in journals such as Oncogene, Journal of Allergy and Clinical Immunology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.